Christophe Allais

9PUBLICATIONS
32CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsOrganometallic chemistryWastewater treatment processesMicrotechnologyOrganic chemical synthesis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease.

Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton

|Feb 04, 2025
Palladium-Catalyzed Enantioselective Stereodivergent Desymmetrization of Cyclic 1,4-Allyldiboronates.

Hao Liang, Lorenzo D Battistoni, Sergei Tcyrulnikov

|Aug 08, 2023
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19.

Christophe Allais, David Bernhardson, Adam R Brown

|May 30, 2023
Development of the Commercial Manufacturing Process for Nirmatrelvir in 17 Months.

Christophe Allais, Christina G Connor, Nga M Do

|Apr 06, 2023
Desymmetrization of Vicinal Bis(boronic) Esters by Enantioselective Suzuki-Miyaura Cross-Coupling Reaction.

Mingkai Zhang, Paul S Lee, Christophe Allais

|May 19, 2022
Stereocontrolled Pericyclic and Radical Cycloaddition Reactions of Readily Accessible Chiral Alkenyl Diazaborolidines.

Mingkai Zhang, Peilin Xu, Alex J Vendola

Pageof 2